$PFE · Pfizer Inc.
Pfizer filed a Form 4 reporting a transaction by Albert Bourla, the company’s Chairman and Chief Executive Officer. The filing discloses that on November 13, 2026, Bourla acquired 21 phantom stock units under the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan. Each unit represents one phantom share of Pfizer common stock, and the units were acquired at a price of $28.89 per unit.
Following the transaction, Bourla beneficially owned 795,823 phantom stock units directly. The filing notes that these units are settled in cash after the reporting person’s separation from service and may be transferred into an alternative investment account at any time. No actual shares of Pfizer common stock were bought or sold in this transaction.
The Form 4 was signed on November 16, 2026, on Bourla’s behalf by an attorney-in-fact.